These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11083629)

  • 41. Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin.
    Fuchs PC; Barry AL; Brown SD
    J Chemother; 1997 Dec; 9(6):391-3. PubMed ID: 9491837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
    Dabernat H
    Int J Antimicrob Agents; 1999 Feb; 11(2):139-43. PubMed ID: 10221417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
    Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
    Callegan MC; Booth MC; Gilmore MS
    Cornea; 2000 Jul; 19(4):539-45. PubMed ID: 10928774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
    Graves A; Henry M; O'Brien TP; Hwang DG; Van Buskirk A; Trousdale MD
    Cornea; 2001 Apr; 20(3):301-5. PubMed ID: 11322420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
    Keverline MR; Kowalski RP; Dhaliwal DK
    J Cataract Refract Surg; 2002 Jun; 28(6):915-6. PubMed ID: 12036617
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS; Ahlén S
    Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
    Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
    Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of natural amino acids on infection with Chlamydia trachomatis.
    Gussmann J; Al-Younes HM; Braun PR; Brinkmann V; Meyer TF
    Microb Pathog; 2008 May; 44(5):438-47. PubMed ID: 18222624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro activity of levofloxacin (l-ofloxacin), ofloxacin and ciprofloxacin against clinical isolates of Streptococcus pneumoniae obtained in England and Wales.
    Johnson AP; Speller DC; Warner M; Domingue G
    J Antimicrob Chemother; 1996 Nov; 38(5):907-8. PubMed ID: 8961064
    [No Abstract]   [Full Text] [Related]  

  • 53. The action of quinolone carboxylic acids on Chlamydia trachomatis in vitro.
    Richmond SJ; Heppleston C; Bailey J
    Biochem Soc Trans; 1986 Apr; 14(2):503-4. PubMed ID: 2940134
    [No Abstract]   [Full Text] [Related]  

  • 54. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
    Johannisson G; Sernryd A; Lycke E
    Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
    Stamm WE; Suchland R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
    Miller D; Alfonso EC
    Cornea; 2004 Apr; 23(3):289-93. PubMed ID: 15084863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
    Kimura M; Kishimoto T; Niki Y; Soejima R
    Antimicrob Agents Chemother; 1993 Apr; 37(4):801-3. PubMed ID: 8494377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
    Pendland SL; Messick CR; Jung R
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.